Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from NewGenIvf Group ( (NIVF) ) is now available.
On February 20, 2025, NewGenIvf Group issued a clarification regarding a previous press release about its Nasdaq listing status. While the company has not yet met the $2.5 million minimum stockholders’ equity requirement set by Nasdaq, it has converted $2.3 million of debt to equity and accessed $4.3 million from its Equity Line of Credit. NewGen is awaiting confirmation from Nasdaq on compliance and has been granted an extension by the Nasdaq Hearings Panel to meet specific listing requirements. As part of its compliance efforts, NewGen conducted a reverse stock split on February 11, 2025, to meet the $1.00 bid price requirement and plans to transition to the Nasdaq Capital Market by February 26, 2025.
More about NewGenIvf Group
NewGenIvf Group is a comprehensive fertility services provider in Asia, offering a range of infertility treatments and assisted reproductive technologies. With clinics in Thailand, Cambodia, and Kyrgyzstan, the company focuses on helping individuals and couples overcome fertility challenges through services like egg and sperm donation and surrogacy.
YTD Price Performance: -71.98%
Average Trading Volume: 737,586
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.11M
For an in-depth examination of NIVF stock, go to TipRanks’ Stock Analysis page.
